Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.815
-0.085 (-4.47%)
At close: Feb 21, 2025, 4:00 PM
1.820
+0.005 (0.30%)
After-hours: Feb 21, 2025, 5:53 PM EST
Ironwood Pharmaceuticals Stock Forecast
IRWD's stock price has decreased by -87.76% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Ironwood Pharmaceuticals stock have an average target of 12, with a low estimate of 5.00 and a high estimate of 21. The average target predicts an increase of 561.16% from the current stock price of 1.82.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Ironwood Pharmaceuticals stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $23 → $14 | Buy | Maintains | $23 → $14 | +671.35% | Jan 30, 2025 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +340.77% | Jan 22, 2025 |
| Leerink Partners | Leerink Partners | Hold Initiates $5 | Hold | Initiates | $5 | +175.48% | Sep 9, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +561.16% | Aug 9, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $14 → $10 | Strong Buy | Maintains | $14 → $10 | +450.96% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
361.81M
from 442.74M
Decreased by -18.28%
Revenue Next Year
293.33M
from 361.81M
Decreased by -18.93%
EPS This Year
0.09
from -6.45
EPS Next Year
0.24
from 0.09
Increased by 149.49%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 382.2M | 394.6M | 560.9M | |||
| Avg | 361.8M | 293.3M | 341.1M | |||
| Low | 344.2M | 258.7M | 238.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -13.7% | 9.1% | 91.2% | |||
| Avg | -18.3% | -18.9% | 16.3% | |||
| Low | -22.3% | -28.5% | -18.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.18 | 0.41 | 1.18 | |||
| Avg | 0.09 | 0.24 | 0.51 | |||
| Low | 0.05 | 0.08 | 0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 332.9% | 398.2% | |||
| Avg | - | 149.5% | 114.9% | |||
| Low | - | -17.1% | -41.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.